Watchlist Manager

Watchlist

Price: 18 EUR

Market Cap: €759.6m

C	Cardiovascular Systems Inc F:R7Y1	US
	Home First Finance Company India Ltd NSE:HOMEFIRST	IN
W	Waitr Holdings Inc OTC:ASAPQ	US
I	IRICO Group New Energy Co Ltd HKEX:438	CN

Income Statement

Currency: USD

	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022
Revenue
Revenue	98 N/A	104 +6%	110 +6%	117 +6%	126 +7%	137 +9%	148 +8%	161 +8%	173 +8%	182 +5%	184 +1%	181 -2%	178 -1%	178 +0%	184 +3%	193 +5%	200 +4%	205 +2%	205 0%	207 +1%	211 +2%	217 +3%	224 +3%	231 +3%	239 +3%	248 +4%	256 +3%	264 +3%	262 -1%	237 -10%	233 -2%	228 -2%	231 +1%	259 +12%	257 -1%	252 -2%	245 -3%	236 -3%	238 +1%	240 +1%
Gross Profit
Cost of Revenue	(23)	(24)	(26)	(27)	(29)	(31)	(33)	(35)	(38)	(40)	(39)	(38)	(36)	(35)	(36)	(37)	(40)	(39)	(39)	(40)	(38)	(39)	(41)	(43)	(45)	(48)	(50)	(52)	(52)	(49)	(49)	(49)	(51)	(61)	(63)	(67)	(68)	(63)	(66)	(66)
Gross Profit	75 N/A	80 +6%	84 +6%	90 +7%	97 +8%	106 +9%	115 +9%	126 +9%	135 +7%	142 +5%	145 +2%	143 -1%	142 -1%	143 +1%	148 +4%	156 +5%	161 +3%	165 +3%	166 +0%	168 +1%	172 +3%	178 +3%	183 +3%	188 +3%	194 +3%	200 +3%	206 +3%	212 +3%	210 -1%	188 -11%	184 -2%	180 -2%	180 +0%	198 +10%	194 -2%	185 -5%	177 -4%	173 -2%	172 -1%	174 +1%
Operating Income
Operating Expenses	(95)	(102)	(108)	(117)	(128)	(139)	(150)	(158)	(168)	(175)	(182)	(190)	(191)	(188)	(193)	(184)	(168)	(167)	(167)	(171)	(173)	(175)	(182)	(187)	(192)	(201)	(210)	(220)	(221)	(215)	(206)	(198)	(202)	(210)	(212)	(212)	(208)	(209)	(210)	(212)
Selling, General & Administrative	(81)	(87)	(92)	(99)	(109)	(118)	(126)	(131)	(139)	(144)	(152)	(160)	(163)	(163)	(158)	(151)	(146)	(144)	(143)	(146)	(147)	(149)	(154)	(158)	(162)	(168)	(173)	(179)	(179)	(170)	(164)	(157)	(157)	(167)	(169)	(169)	(170)	(171)	(173)	(174)
Research & Development	(15)	(15)	(16)	(17)	(19)	(21)	(24)	(27)	(29)	(31)	(31)	(30)	(28)	(26)	(24)	(23)	(23)	(23)	(24)	(24)	(26)	(27)	(28)	(29)	(31)	(33)	(37)	(40)	(41)	(43)	(42)	(40)	(44)	(41)	(42)	(41)	(37)	(37)	(36)	(36)
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(0)	0	0	0	(0)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(10)	(10)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	(20) N/A	(22) -14%	(24) -7%	(26) -10%	(31) -16%	(33) -9%	(35) -4%	(33) +6%	(34) -3%	(33) +3%	(38) -15%	(48) -26%	(49) -4%	(46) +7%	(45) +2%	(28) +36%	(8) +74%	(2) +79%	(1) +8%	(3) -95%	(1) +81%	2 N/A	1 -55%	2 +65%	2 +1%	(1) N/A	(4) -357%	(8) -99%	(11) -43%	(27) -148%	(23) +16%	(19) +16%	(22) -15%	(12) +45%	(18) -54%	(27) -48%	(31) -15%	(36) -15%	(39) -8%	(39) +0%
Pre-Tax Income
Interest Income Expense	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(0)	(0)	(0)	0	0	0	0	0	0	0	(0)	(0)	(0)	(1)	(0)	(0)	0	1	1	1	1	0	(0)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(0)	1
Non-Reccuring Items	(1)	(1)	(1)	(1)	(1)	(1)	(1)	0	0	0	0	0	(10)	(10)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Pre-Tax Income	(22) N/A	(24) -10%	(26) -9%	(29) -11%	(33) -12%	(35) -9%	(36) -3%	(33) +9%	(34) -3%	(33) +3%	(38) -15%	(48) -26%	(60) -25%	(56) +6%	(45) +20%	(28) +36%	(7) +74%	(2) +77%	(2) -6%	(3) -80%	(1) +65%	2 N/A	1 -50%	2 +98%	2 +20%	(0) N/A	(3) -4 800%	(7) -132%	(10) -53%	(27) -159%	(23) +14%	(20) +14%	(23) -16%	(13) +43%	(20) -49%	(29) -45%	(32) -13%	(37) -14%	(39) -6%	(38) +3%
Net Income
Tax Provision	0	0	0	0	0	0	0	0	0	0	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)	(0)
Income from Continuing Operations	(22)	(24)	(26)	(29)	(33)	(35)	(36)	(33)	(34)	(33)	(38)	(48)	(60)	(56)	(45)	(28)	(7)	(2)	(2)	(3)	(1)	2	1	2	2	(0)	(3)	(7)	(11)	(27)	(24)	(20)	(23)	(13)	(20)	(29)	(33)	(37)	(39)	(38)
Net Income (Common)	(22) N/A	(24) -10%	(26) -9%	(29) -11%	(33) -12%	(35) -9%	(36) -3%	(33) +9%	(34) -3%	(33) +3%	(38) -15%	(48) -26%	(60) -25%	(56) +6%	(45) +20%	(28) +36%	(7) +74%	(2) +76%	(2) -7%	(3) -76%	(1) +63%	2 N/A	1 -53%	2 +111%	2 +18%	(0) N/A	(3) -1 112%	(7) -123%	(11) -51%	(27) -157%	(24) +14%	(20) +14%	(23) -15%	(13) +42%	(20) -49%	(29) -45%	(33) -13%	(37) -14%	(39) -5%	(38) +3%
EPS (Diluted)	-1.01 N/A	-0.99 +2%	-1.06 -7%	-1.07 -1%	-1.07 N/A	-1.14 -7%	-1.16 -2%	-1.04 +10%	-1.07 -3%	-1.03 +4%	-1.18 -15%	-1.47 -25%	-1.83 -24%	-1.71 +7%	-1.35 +21%	-0.87 +36%	-0.23 +74%	-0.05 +78%	-0.06 -20%	-0.1 -67%	-0.04 +60%	0.05 N/A	0.02 -60%	0.05 +150%	0.06 +20%	-0.01 N/A	-0.09 -800%	-0.21 -133%	-0.31 -48%	-0.78 -152%	-0.61 +22%	-0.52 +15%	-0.6 -15%	-0.34 +43%	-0.51 -50%	-0.74 -45%	-0.83 -12%	-0.94 -13%	-0.98 -4%	-0.95 +3%

Income Statement Balance Sheet Cash Flow Statement

Cardiovascular Systems Inc
F:R7Y1

Income Statement

Earnings Waterfall
Cardiovascular Systems Inc

Income Statement
Cardiovascular Systems Inc

See Also

Company

Help

Tools

Stocks

Cardiovascular Systems Inc F:R7Y1

Income Statement

Earnings Waterfall Cardiovascular Systems Inc

Income Statement Cardiovascular Systems Inc

See Also

Company

Help

Tools

Stocks

Cardiovascular Systems Inc
F:R7Y1

Earnings Waterfall
Cardiovascular Systems Inc

Income Statement
Cardiovascular Systems Inc